Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
作者： Paresh Soni
DOI:
关键词:
摘要: In various embodiments, the present invention provides methods of reducing risk a cardiovascular event in subject on statin therapy and, particular, method having fasting baseline triglyceride level about 135 mg/dL to 500 mg/dL, and administering pharmaceutical composition comprising 1 g 4 eicosapentaenoic acid ethyl ester or derivative thereof.
glgoo.top参考文章(1,073)
V. Lyngmo, B. Svensson, J.-B. Hansen, J.-O. Olsen, L. Wilsgard, Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men. European Journal of Clinical Nutrition. ,vol. 47, pp. 497- 507 ,(1993)
K.-I. Hirano, M. Kubo, N. Sakai, S. Tarui, S. Nozaki, Y. Matsuzawa, Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia. International Journal for Vitamin and Nutrition Research. ,vol. 62, pp. 256- 260 ,(1992)
Makoto Kinoshita, [Anti-hyperlipidemic agents]. Nihon rinsho. Japanese journal of clinical medicine. ,vol. 60, pp. 968- 974 ,(2002)
Huizhen Zhang, John Westcott Finley, Mary M. Opet, Irene Hoyt Hoyt, Song Gao, John Weldon Finley, Igor A. Mezine, Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks ,(2006)
James D. Otvos, Method and apparatus for measuring classes and subclasses of lipoproteins ,(1993)
Jun Sasaki, Hideki Origasa, Yuji Matsuzawa, Shinichi Oikawa, Hiroshige Itakura, Mitsuhiro Yokoyama, Yasushi Saito, Kunio Shirato, Akira Kitabatake, Noriaki Nakaya, Kazuyuki Shimada, Hitoshi Hishida, Toshiie Sakata, Yuichi Ishikawa, Toru Kita, Masunori Matsuzaki, Composition for prevention of occurrence of cardiovascular event ,(2006)
Cesare R Sirtori, Gaetano Crepaldi, Enzo Manzato, Mario Mancini, Angela Rivellese, Rodolfo Paoletti, Franco Pazzucconi, Franco Pamparana, Eduardo Stragliotto, One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: Reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations Atherosclerosis. ,vol. 137, pp. 419- 427 ,(1998) , 10.1016/S0021-9150(97)00298-0
Takashi YANO, Kiyoshi MIZUGUCHI, Kazuhiro TAKASUGI, Yasuo TANAKA, Masami SATO, [Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on low density lipoprotein in rabbits]. Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan. ,vol. 115, pp. 843- 851 ,(1995) , 10.1248/YAKUSHI1947.115.10_843
Michael Dansinger, Ernst Schaefer, Joi Gleason, Katalin Horvath, Peter Gillies, Ivor Asztalos, Effect of a Novel Eicosapentaenoic Acid-Rich Oil on Serum Cholesterol in Man: Comparison to Docosahexaenoic Acid The FASEB Journal. ,vol. 24, ,(2010)